Supermax currently exports 58% of production under its own brands via its own distribution centres and 40% through independent distributors. The remaining 2% is for original equipment manufacturer production.

Its products are sold to over 165 countries, with the largest contributor being the Americas region which contributed 51% of revenue for FY20. Asia/Oceania and Europe each contributed 23% to its FY20 revenue.

Supermax said the continuing upward trend of the average selling price (ASP) has not been reflected in the current quarter.

Supermax expects its solid run to continue throughout the year on soaring demand for medical protective gears and higher glove prices.

The world will continue to face a glove shortage until 2023, said former MARGMA president Denis Low Jau Foo, given that manufacturers are currently still in an “oversold” position.

He also said average selling prices (ASPs) of gloves will not see a sharp decline because the majority of glove producers today, which have big government contracts, are facing difficulty in fulfilling the demand.

MARGMA expects a shortfall of 80 bil pieces of rubber gloves this year as demand continues to outstrip supply.

Uptrend

Building new disposable glove production lines and factories takes time – from one to three years – and most additional nitrile capacity is already sold out through 2021.

Prices of gloves are still rising in 2021 even with vaccination campaigns under way around the world.
Every single month, the price of gloves has gone up. It’s a nice moneymaking opportunity if you’re a manufacturer.

Thanks to cheap labor and a quirk of geography—natural rubber and the chemicals that make synthetic rubbers like nitrile are mainly produced in Asia—the glove market is dominated by companies in Southeast Asia. That means it’s nearly impossible for countries outside the region to make enough gloves domestically, as they did for masks and gowns.

In its March 2021 projections, the Malaysian Rubber Glove Manufacturers Association
(“MARGMA”) expects Malaysia’s glove export revenue for 2021 to hit RM38 billion compared with RM35.3
billion in 2020. MARGMA projects annual global demand growth of 15-20% moving forward, with global
demand at 420 billion pieces for 2021.

Global shortage of gloves to persist for next two to three years.

) States across the country are reporting a rise in Covid-19 cases. But in one state -- Michigan -- another surge has overwhelmed hospitals and healthcare workers who were already exhausted, one local health leader says.

U.S. intelligence officials have little comfort to offer a pandemic-weary planet about where the world is heading in the next 20 years. Short answer: It looks pretty bleak.

People may need to get vaccinated against Covid-19 annually, just like seasonal flu shots, over the next several years, Johnson & Johnson CEO Alex Gorsky told CNBC.

Anti-COVID vaccines could become annual affair: study.

COVID Vaccine Rollouts Elevated the Demand for Nitrile Gloves.

The overall current demand is 585 billions gloves a year according to market analysts. However current production can only make 370 billions gloves a year and new manufacturers for 2021 will only be able to make an additional 50 billion gloves, thus creating a shortfall of 165 billion gloves.

Only time will tell, but as of right now, it looks like an annual booster may be in the cards for COVID-19 vaccines.

Pfizer CFO Frank D’Amelio said that the COVID-19 vaccine might have to shift gears if the virus becomes endemic to our society. D’Amelio said that it’s “increasingly likely that an annual revaccination is going to take place,” and that it will be necessary for the foreseeable future, according to FiercePharma.

Vaccines often aren’t effective forever — the COVID-19 vaccine might be a semi-annual or annual vaccine that we need to get like the flu.

Asian countries should not kowtow to US.

Emanuele Capobianco, IFRC’s Director of Health, said:

“We are very concerned about this convergence of a potential false sense of security due to the rollout of vaccines, the emergence of new variants, and the impact of holiday-season travel. Our first line of defence against the virus remains our individual behaviour. Beyond this, the ability of Governments to take swift actions based on scientific evidence is also key to slowing down the pandemic.

27 March 2021
New cases worldwide = 614489
New cases USA = 60302

The U.S. is in a delicate position as Covid cases increase alongside vaccinations, experts warn

Daily Covid-19 cases are increasing once again after months of declines, a troubling sign as more Americans let down their guard, experts say.

More transmissible virus variants could lead to more cases, hospitalizations and deaths among those without access to a vaccine, they warn.

https://www.cnbc.com/2021/03/28/the-us-is-in-a-delicate-position-as-covid-cases-increase-alongside-vaccinations-experts-warn-.html

The ongoing emergence of new variants behave almost like new viruses. A clinical vaccine trial in South Africa showed that people in the placebo group who had previously been infected with one strain had no immunity against its mutated descendant and became reinfected. There are similar reports from parts of Brazil that had massive outbreaks and subsequently suffered renewed epidemics.

pump and dump.

Operation Warp Speed at a crawl: Adequately vaccinating Americans will take 10 years at current pace.

https://www.nbcnews.com/news/us-news/current-rate-it-ll-be-10-years-americans-adequately-vaccinated-n1252486

Boston doctor has severe allergic reaction to Moderna COVID vaccine -NYT

https://www.thestar.com.my/news/world/2020/12/26/boston-doctor-has-severe-allergic-reaction-to-moderna-covid-vaccine--nyt

Boston doctor has severe allergic reaction to Moderna COVID vaccine -NYT

https://www.thestar.com.my/news/world/2020/12/26/boston-doctor-has-severe-allergic-reaction-to-moderna-covid-vaccine--nyt

Hospitals face shortage of medical gloves

https://www3.nhk.or.jp/nhkworld/en/news/20201208_44/

Major questions are still outstanding, even about vaccines, such as long-term safety, timely and effective distribution, and vaccine acceptance by the population, to say nothing of lingering epidemiological questions such as the duration of immunity.

Even with the vaccine the virus is "not going away", says Sir Jeremy Farrar, a member of the government's Sage advisory group.

It is, he says, now part of humanity and here to stay. Instead, the most we can hope for is providing some protection to those who are most at risk.

The sad reality is that, despite the vaccine breakthrough, we are still going to have to learn to live with Covid this winter - and beyond.

Yes, We Have COVID-19 Vaccines That Are 95% Effective. But That Doesn’t Mean the End of the Pandemic is Near

https://time.com/5913113/covid-19-vaccine/

https://www.bernama.com/en/business/news.php?id=1906546

https://www.bernama.com/en/business/news.php?id=1906546

Should you rush to get a COVID-19 vaccination? One specialist in Japan says he won't

https://mainichi.jp/english/articles/20201120/p2a/00m/0na/008000c

Should you rush to get a COVID-19 vaccination? One specialist in Japan says he won't

https://mainichi.jp/english/articles/20201120/p2a/00m/0na/008000c

Instead of traditional dividend payments, buybacks have been viewed as a flexible practice of returning excess cash flow. Buybacks can be seen as an efficient way to put money back into its shareholders' pockets, as demonstrated by Apple’s (AAPL) capital return programs.

Buying back its own shares may be regarded as a sign of management’s confidence in a company's prospects.

Gloves in demand for hospitals facing shortages due to COVID-19:

https://www.fiercehealthcare.com/hospitals/gloves-demand-for-hospitals-facing-shortages-due-to-covid-19-premier

Malaysian manufacturer Top Glove, which describes itself as the world's biggest producer of rubber gloves, said it is seeing orders for 11-12 billion a month, compared with 4.5 billion prior to the pandemic.

As a result, customers must now wait nearly 600 days for their orders to be filled, compared with a normal delivery time of 30-40 days, said chief executive, Lim Wee Chai.

"We have health centres calling us every day trying to get their hands on gloves," said Sebastien Lenoble, director of Netherlands-based Shield Scientific, which markets gloves for medical, industrial and laboratory applications.

"These aren't our usual clients. They're coming to us because they're desperate to find gloves."

"We have health centres calling us every day trying to get their hands on gloves," said Sebastien Lenoble, director of Netherlands-based Shield Scientific, which markets gloves for medical, industrial and laboratory applications.

"These aren't our usual clients. They're coming to us because they're desperate to find gloves."

US-based Allied Market Research estimates that the global disposable gloves market amounted to $6.8 billion in 2019, and is expected to nearly triple to $18.8 billion by 2027.

US-based Allied Market Research estimates that the global disposable gloves market amounted to $6.8 billion in 2019, and is expected to nearly triple to $18.8 billion by 2027.

Hartalega likely to benefit from nitrile glove shortage.

Scientists around the world are in a race to successfully develop the first COVID-19 vaccine but while a major step forward, Jerome Kim, director general of the International Vaccine Institute, has told The Agenda with Stephen Cole it won't in itself solve the pandemic.

The next challenge will be to ensure it is delivered safely and efficiently to billions across the world, so the logistical planning of the operation will be key.

Scientists around the world are in a race to successfully develop the first COVID-19 vaccine but while a major step forward, Jerome Kim, director general of the International Vaccine Institute, has told The Agenda with Stephen Cole it won't in itself solve the pandemic.

The next challenge will be to ensure it is delivered safely and efficiently to billions across the world, so the logistical planning of the operation will be key.

Even those who can get vaccinated immediately, it takes weeks for the immune system to build antibodies against the vaccine and a booster dose may be needed.

At least two-thirds of the community have to take the vaccine to attain herd immunity, said Paul A. Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

Even those who can get vaccinated immediately, it takes weeks for the immune system to build antibodies against the vaccine and a booster dose may be needed.

At least two-thirds of the community have to take the vaccine to attain herd immunity, said Paul A. Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.